The Impact of Chemotherapy on Cardiovascular Mortality across Breast Cancer Subtypes

CONCLUSION: Breast cancer patients on chemotherapy face an elevated cardiovascular mortality risk, especially with aggressive subtypes (HER2-enriched, TNBC), advanced age, or HER2+/HR+ cancer receiving long-term treatment.PMID:38392041 | PMC:PMC10887634 | DOI:10.3390/curroncol31020047

Source: Current Oncology - February 23, 2024 Category: Cancer & Oncology Authors: To àn Minh Ngô Ánh Ngọc Lê D ương Phạm Hoàng Đinh Source Type: research